info icon

Melanoma in situ of scalp and neck

CD2_INSITU_MELANOMA_SCALPNECK

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D03.4&
  • Cause of death: ICD-10 D03.4&

2 out of 7 registries used, show all original rules.

76

4. Check minimum number of events

None

76

5. Include endpoints

None

76

6. Filter based on genotype QC (FinnGen only)

76

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D03
Name in latin
Melanoma in situ verticis cranii

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 76 25 51
Unadjusted period prevalence (%) 0.02 0.01 0.02
Median age at first event (years) 70.48 71.86 69.80

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
70
Matched controls
700
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
100.6
70
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
55.1
42.4
57
51
L57.0
ICD-10 Finland
Actinic keratosis
9.1
12.9
30
53
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.8
12.3
29
52
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
142.5
11.8
12
*
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
52.4
11.4
13
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
9.9
10.2
21
29
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.0
9.2
29
74
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
15.5
8.8
14
11
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.2
7.4
18
32
S18
ICPC
Laceration/cut
4.1
7.3
48
242
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
19.1
7.0
10
6
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
25.4
6.9
9
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
76.5
6.5
7
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
29.6
6.4
8
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
10.1
6.4
12
14

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
44
71
13.34
30.09
1.9
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
60
240
8.13
15.20
4.3
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
50
313
2.75
4.21
6.2
5.0
g/l
35.2
34.6
0.36
43
295
(42870588) Differential panel, method unspecified - Blood
40
225
2.64
4.17
9.0
5.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
19
75
3.04
3.82
1.6
1.4
titre
573.3
429.5
—
6
19
(4035726)
16
61
3.06
3.39
1.4
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
115
2.59
3.35
3.5
2.9
e6/l
1.3
1.7
0.14
15
68
(3013115) Eosinophils [#/volume] in Blood
49
329
2.38
3.20
9.3
5.6
e9/l
0.2
0.2
0.82
41
290
(3018095) Leukocytes [#/volume] in Urine
41
257
2.29
3.12
4.9
3.7
e6/l
305.2
70.2
0.71
29
192
(3002582) Erythrocytes [#/volume] in Urine
37
226
2.24
2.96
4.1
3.3
e6/l
99.9
56.4
0.37
28
178
(3001604) Monocytes [#/volume] in Blood
47
320
2.23
2.84
9.0
5.2
e9/l
0.7
0.6
0.39
37
267
(3006315) Basophils [#/volume] in Blood
47
321
2.22
2.80
9.0
5.3
e9/l
0.0
0.0
0.24
38
273
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
60
455
2.51
2.77
3.3
3.7
pmol/l
15.4
15.0
0.49
50
380
(36304419) Bacteria [Presence] in Urine
33
197
2.19
2.75
3.8
2.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
25
3.94
2.67
1.0
1.2
—
—
—
0
0
(3036489) Thrombin time
8
21
4.13
2.54
1.5
2.4
s
23.3
21.4
—
8
21
(3019198) Lymphocytes [#/volume] in Blood
47
329
2.12
2.54
9.2
5.2
e9/l
1.8
1.7
0.26
39
294
(3009542) Hematocrit [Volume Fraction] of Blood
66
533
2.81
2.50
22.2
18.7
%
41.1
39.2
1.41
40
319
(3005719) IgG [Mass/volume] in Serum or Plasma
12
46
2.91
2.50
2.8
2.7
g/l
10.7
10.1
0.15
12
36
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
123
2.25
2.46
3.2
2.5
e6/l
0.4
1.0
1.08
14
75
(3015377) Calcium [Moles/volume] in Serum or Plasma
36
231
2.06
2.42
4.9
3.8
mmol/l
2.4
2.3
0.65
30
194
(3021589) Normoblasts [#/volume] in Blood
41
276
2.05
2.42
12.8
11.2
e9/l
0.0
0.0
0.50
29
232
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
46
327
2.03
2.30
8.7
7.1
mmol/l
1.2
1.2
0.67
41
291
(3007164) IgA [Mass/volume] in Serum or Plasma
20
104
2.25
2.27
1.9
1.6
g/l
2.4
3.3
0.71
14
55
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
28
168
2.06
2.22
1.9
1.7
mmol/l
1.6
1.3
0.58
21
130
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
7
19
3.95
2.21
1.3
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
20
3.74
2.11
1.4
2.3
%
75.3
84.3
—
7
20
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
70
608
2.91
2.07
22.0
17.3
ml/min/173m2
72.0
73.3
0.19
60
497
(3013650) Neutrophils [#/volume] in Blood by Automated count
51
385
1.99
2.05
12.6
9.6
e9/l
4.4
4.3
0.04
39
334
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
64
528
2.34
1.98
9.5
8.1
u/l
77.0
82.2
0.60
58
488
(3034770) Mitochondria Ab [Titer] in Serum
6
16
3.98
1.97
1.5
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
70
613
2.80
1.91
5.8
5.1
mmol/l
4.4
4.4
0.19
61
550
(40760888) Immunoglobulin light chains.free panel - Serum
6
17
3.74
1.87
12.2
6.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
47
353
1.87
1.83
10.5
8.2
mmol/l
1.2
1.2
0.33
38
292
(3030467) Casts [#/volume] in Urine by Automated count
32
213
1.87
1.83
4.0
2.9
e6/l
0.1
0.3
1.34
23
167
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
47
0.00
1.78
0.0
2.0
—
7.3
—
0
39
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
13
4.04
1.74
1.0
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
13
4.04
1.74
1.0
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
11
49
2.46
1.73
1.1
2.0
%
1.4
1.8
—
6
36
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
49
2.46
1.73
1.1
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
31
2.76
1.71
1.0
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
208
1.83
1.71
4.3
3.2
ug/l
0.7
0.8
0.18
21
149
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
25
2.98
1.69
1.6
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
71
2.19
1.67
2.8
1.7
—
—
—
0
0
(3000492) Spirometry study
11
50
2.40
1.66
1.8
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
14
3.74
1.64
1.4
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
19
110
1.97
1.62
2.8
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
68
598
2.30
1.61
4.9
4.5
mmol/l
1.4
1.3
0.57
57
526
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
39
285
1.76
1.59
2.0
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
51
2.35
1.59
1.2
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
31
213
1.77
1.56
5.2
4.5
ph
7.4
7.4
—
5
45
(3052851) Hemolysis interference index of Serum or Plasma
5
15
3.49
1.55
3.0
4.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
15
3.49
1.55
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
69
610
2.42
1.53
6.0
5.1
mmol/l
1.4
1.4
0.05
58
539
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
38
2.55
1.52
2.8
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
38
2.55
1.52
3.3
2.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
17
97
1.97
1.50
1.5
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
57
471
1.84
1.47
4.9
4.0
mm/h
14.4
14.2
0.03
52
422
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
37
271
1.71
1.47
4.6
3.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
16
3.27
1.46
1.4
1.6
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
29
2.55
1.43
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
66
574
2.14
1.42
5.1
4.5
mu/l
2.2
2.1
0.12
55
493
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
17
3.07
1.38
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
17
3.07
1.38
1.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
68
609
2.11
1.33
7.7
7.1
mmol/mol
41.4
41.7
0.07
58
560
(3004588) Protein electrophoresis panel - Serum or Plasma
12
63
2.07
1.31
4.6
2.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
32
232
1.66
1.28
4.5
3.3
mmol/l
8.0
7.6
0.16
24
178
(3037467) Urinalysis macro (dipstick) panel - Urine
55
459
1.72
1.26
5.2
4.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
64
2.04
1.26
1.1
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
11
57
2.09
1.24
1.9
3.2
u/l
26.2
44.3
0.77
11
45
(3024928) Oxygen saturation in Venous blood
5
19
2.74
1.23
3.6
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
13
73
1.94
1.20
2.8
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
39
2.17
1.19
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
20
2.60
1.17
1.2
1.6
—
—
—
0
0
(3012544) pH of Venous blood
13
75
1.88
1.11
2.7
4.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
21
2.47
1.11
2.8
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
21
2.47
1.11
1.4
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
25
177
1.61
1.07
2.6
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
34
260
1.56
1.06
2.4
2.3
nmol/l
83.5
77.3
0.53
29
210
(3000494) Fungus identified in Specimen by Culture
16
101
1.74
1.04
1.4
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
35
2.10
1.03
1.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
27
2.32
0.96
1.3
2.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
30
230
1.50
0.89
5.1
3.4
mg/l
49.4
64.8
0.29
24
156
(3036481) Cortisol [Moles/volume] in Serum or Plasma
11
65
1.81
0.88
2.8
1.6
nmol/l
370.5
390.2
0.09
11
60
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
99
1.64
0.83
5.5
4.9
%
33.1
32.3
—
9
58
(3013512) EKG study
30
234
1.47
0.81
5.6
5.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
26
0.00
0.80
0.0
6.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
39
321
1.44
0.79
9.3
11.6
inr
1.2
1.4
—
9
94
(3021601) Nitrite [Presence] in Urine by Test strip
39
322
1.43
0.78
5.2
5.4
estimate
0.0
0.0
—
8
63
(3020682) Albumin/Creatinine [Ratio] in Urine
31
248
1.42
0.72
5.6
4.2
mg/mmol
10.3
9.2
0.10
21
161
(3030981) Hyaline casts [#/volume] in Urine by Automated count
7
41
1.78
0.72
3.0
4.3
e6/l
0.0
0.1
—
7
41
(3009261) Glucose [Presence] in Urine by Test strip
39
326
1.40
0.71
4.4
4.1
estimate
0.0
0.0
—
8
57
(3019225) pH of Specimen
11
73
1.59
0.60
9.4
5.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
36
1.72
0.58
2.7
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
22
172
1.39
0.57
10.3
6.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
66
1.59
0.56
3.7
3.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
64
1.46
0.54
11.9
10.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
322
0.75
0.52
4.7
4.5
ng/l
40.9
61.9
0.58
20
251
(3035350) Ketones [Presence] in Urine by Test strip
37
320
1.30
0.49
4.5
4.1
estimate
0.0
0.0
—
8
64
(3044640) Blood type and Crossmatch panel - Blood
28
233
1.32
0.48
2.7
2.7
—
—
—
0
0
(4010399)
7
50
1.44
0.46
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
141
1.36
0.46
4.6
4.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
12
87
1.45
0.45
5.3
5.2
ug/l
4.5
60.2
0.57
12
69
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
34
1.50
0.41
1.6
2.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
2.1
—
5.1
—
0
6
(3028271) Lactate [Moles/volume] in Capillary blood
0
17
0.00
0.41
0.0
2.2
—
1.6
—
0
17
(3022145) Colonoscopy Study observation
9
69
1.34
0.39
1.8
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
15
117
1.35
0.39
1.2
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
67
636
1.45
0.39
18.6
18.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
298
1.26
0.38
5.6
4.7
%
19.7
21.4
0.34
20
165
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
42
378
1.25
0.37
6.9
5.4
ug/l
2.4
3.1
0.34
33
329
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
35
310
1.24
0.35
3.8
4.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
54
1.33
0.31
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
16
131
1.28
0.30
5.6
4.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
16
131
1.28
0.30
3.1
1.8
s
31.2
29.8
0.28
16
126
(3023368) Bacteria identified in Blood by Culture
27
236
1.22
0.30
5.2
4.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
35
316
1.20
0.28
2.6
2.1
pmol/l
83.8
92.8
0.47
20
155
(3026008) Bacteria identified in Urine by Culture
25
220
1.20
0.25
3.6
3.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
21
183
1.20
0.23
4.1
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
22
193
1.20
0.23
5.0
4.4
estimate
0.0
0.0
—
8
60
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
98
1.27
0.23
5.8
9.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
12
0.00
0.21
0.0
2.3
—
90.7
—
0
12
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
4.4
—
105.5
—
0
13
(3041354) Potassium [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
4.4
—
4.2
—
0
13
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
4.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
14
0.00
0.20
0.0
4.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.5
—
90.9
—
0
14
(3041096) Erythrocytes [Presence] in Urine by Automated
21
188
1.16
0.17
3.8
3.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
70
1.16
0.17
3.1
3.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
88
0.77
0.15
1.6
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
15.8
7.1
mmol/l
25.6
24.9
—
5
48
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
48
1.04
0.09
20.2
9.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
53
1.14
0.09
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
64
1.10
0.08
2.4
4.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
8
78
1.03
0.07
2.0
2.4
g/l
0.3
0.2
—
8
70
(3022948) Iron [Moles/volume] in Serum or Plasma
15
139
1.10
0.06
2.0
2.3
umol/l
16.2
12.8
1.15
15
123
(3003694) ABO and Rh group [Type] in Blood
17
160
1.08
0.04
1.2
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
121
1.09
0.04
1.8
2.2
%
27.5
21.7
0.95
13
104
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
27
260
1.06
0.04
4.6
4.4
—
—
—
0
0
(3044889) 12 lead EKG panel
48
483
0.98
0.00
5.5
4.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
13
126
1.04
0.00
1.9
2.2
g/l
2.2
2.3
0.26
13
110
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
18
176
1.03
0.00
1.3
1.8
pmol/l
342.1
449.6
2.29
13
144
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(4306422)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
7
0.00
0.00
0.0
2.4
—
0.2
—
0
7
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
15.7
—
0
7
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
26.8
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
101.8
—
0
8
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
2.6
—
0
8
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
3.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5
59
0.84
0.00
2.8
2.3
ug/g
116.4
220.3
—
5
48
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
61
0.98
0.00
7.5
3.0
kpa
4.6
4.9
—
6
54
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
90
1.00
0.00
2.1
3.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
7.0
—
0
5
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: CD2_INSITU_MELANOMA_SCALPNECK – Melanoma in situ of scalp and neck

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).